Celcuity (CELC) Stock Forecast, Price Target & Predictions
CELC Stock Forecast
Celcuity stock forecast is as follows: an average price target of $31.50 (represents a 105.08% upside from CELC’s last price of $15.36) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
CELC Price Target
CELC Analyst Ratings
Celcuity Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 15, 2024 | Bradley Canino | Stifel Nicolaus | $39.00 | $16.57 | 135.37% | 153.91% |
May 30, 2024 | Bradley Canino | Stifel Nicolaus | $40.00 | $15.28 | 161.78% | 160.42% |
Mar 28, 2024 | Gil Blum | Needham | $24.00 | $18.16 | 32.16% | 56.25% |
Celcuity Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $39.00 | $34.33 |
Last Closing Price | $15.36 | $15.36 | $15.36 |
Upside/Downside | -100.00% | 153.91% | 123.50% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 15, 2024 | Cowen & Co. | Buy | Buy | Hold |
Jul 22, 2024 | Jefferies | Buy | Buy | Hold |
Mar 28, 2024 | Craig-Hallum | Buy | Buy | Hold |
Mar 28, 2024 | Needham | Buy | Buy | Hold |
Oct 11, 2021 | Canaccord Genuity | - | Buy | Initialise |
Celcuity Financial Forecast
Celcuity Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $28.60M | $14.30M | $92.80M | $92.80M | $1.27M | $550.00K | - | - | $4.41M | $1.89M | - |
High Forecast | $28.60M | $14.30M | $92.80M | $92.80M | $1.27M | $550.00K | - | - | $4.41M | $1.89M | - |
Low Forecast | $28.60M | $14.30M | $92.80M | $92.80M | $1.27M | $550.00K | - | - | $4.41M | $1.89M | - |
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | - | - | 4 | 5 | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Celcuity EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | - | - | 4 | 5 | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Celcuity Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | - | - | 4 | 5 | - |
Net Income | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-21.14M | $-28.45M | $-34.22M | $-30.37M | $-32.99M | $-31.29M | $-30.06M | $-28.14M | $-27.13M | $-25.10M | $-26.09M |
High Forecast | $-21.14M | $-28.45M | $-34.22M | $-30.37M | $-32.99M | $-31.29M | $-30.06M | $-28.14M | $-27.13M | $-21.24M | $-26.09M |
Low Forecast | $-21.14M | $-28.45M | $-34.22M | $-30.37M | $-32.99M | $-31.29M | $-30.06M | $-28.14M | $-27.13M | $-27.80M | $-26.09M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Celcuity SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | - | - | 4 | 5 | - |
SG&A | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Celcuity EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | - | - | 4 | 5 | - |
EPS | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-0.55 | $-0.74 | $-0.89 | $-0.79 | $-0.86 | $-0.81 | $-0.78 | $-0.73 | $-0.71 | $-0.65 | $-0.68 |
High Forecast | $-0.55 | $-0.74 | $-0.89 | $-0.79 | $-0.86 | $-0.81 | $-0.78 | $-0.73 | $-0.71 | $-0.55 | $-0.68 |
Low Forecast | $-0.55 | $-0.74 | $-0.89 | $-0.79 | $-0.86 | $-0.81 | $-0.78 | $-0.73 | $-0.71 | $-0.72 | $-0.68 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Celcuity Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ANTX | AN2 Therapeutics | $1.08 | $8.75 | 710.19% | Buy |
HOWL | Werewolf Therapeutics | $2.26 | $12.00 | 430.97% | Buy |
MOLN | Molecular Partners | $6.06 | $29.00 | 378.55% | Buy |
AVTE | Aerovate Therapeutics | $2.72 | $13.00 | 377.94% | Hold |
ANEB | Anebulo Pharmaceuticals | $1.89 | $6.00 | 217.46% | Buy |
ACRV | Acrivon Therapeutics | $7.85 | $22.00 | 180.25% | Buy |
ANAB | AnaptysBio | $19.94 | $52.33 | 162.44% | Buy |
RZLT | Rezolute | $5.44 | $13.50 | 148.16% | Buy |
MLYS | Mineralys Therapeutics | $13.50 | $30.00 | 122.22% | Buy |
CCCC | C4 Therapeutics | $6.45 | $13.50 | 109.30% | Buy |
CELC | Celcuity | $15.36 | $31.50 | 105.08% | Buy |
ADAG | Adagene | $3.05 | $5.00 | 63.93% | Buy |
EWTX | Edgewise Therapeutics | $34.48 | $45.00 | 30.51% | Buy |
IKNA | Ikena Oncology | $1.72 | $1.33 | -22.67% | Buy |
CYT | Cyteir Therapeutics | $3.02 | $2.00 | -33.77% | Sell |
CELC Forecast FAQ
Is Celcuity a good buy?
Yes, according to 5 Wall Street analysts, Celcuity (CELC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of CELC's total ratings.
What is CELC's price target?
Celcuity (CELC) average price target is $31.5 with a range of $24 to $39, implying a 105.08% from its last price of $15.36. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Celcuity stock go up soon?
According to Wall Street analysts' prediction for CELC stock, the company can go up by 105.08% (from the last price of $15.36 to the average price target of $31.5), up by 153.91% based on the highest stock price target, and up by 56.25% based on the lowest stock price target.
Can Celcuity stock reach $20?
CELC's average twelve months analyst stock price target of $31.5 supports the claim that Celcuity can reach $20 in the near future.
What are Celcuity's analysts' financial forecasts?
Celcuity's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.82M (high $1.82M, low $1.82M), average EBITDA is $0 (high $0, low $0), average net income is $-122M (high $-122M, low $-122M), average SG&A $0 (high $0, low $0), and average EPS is $-3.186 (high $-3.186, low $-3.186). CELC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $228.5M (high $228.5M, low $228.5M), average EBITDA is $0 (high $0, low $0), average net income is $-114M (high $-114M, low $-114M), average SG&A $0 (high $0, low $0), and average EPS is $-2.97 (high $-2.97, low $-2.97).